Re: Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs
Human Cell · 2024
DOI: 10.1007/s13577-024-01093-8 ↗Kurz gefasst
Leserbrief in der Zeitschrift Human Cell, 2024. Verfasst von Raymond Dalgleish. Beteiligte Einrichtung: Department of Genetics and Genome Biology, University of Leicester, University Road, Leicester, LE1 7RH, UK. raymond.dalgleish@leicester.ac.uk. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, CRISPR-Cas Systems, Mutation, Collagen Type I, alpha 1 Chain. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Genome Biology, University of Leicester, University Road, Leicester, LE1 7RH, UK. raymond.dalgleish@leicester.ac.uk.
Zitieren
APA
Dalgleish, R. (2024). Re: Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs. Human Cell. https://doi.org/10.1007/s13577-024-01093-8
Vancouver
Dalgleish R. Re: Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs. Human Cell. 2024. doi:10.1007/s13577-024-01093-8
BibTeX
@article{Dalgleish2024,
author = {Dalgleish, Raymond},
title = {Re: Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01093-8}
}
EUVIMED